(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-3a-(3-(1-(5-chloropyrimidin-2-yl)cyclopropyl)-2-oxooxazolidin-5-yl)-1-isopropyl-5a,5b,8,8,11a-pentamethyl-2-oxo-3,3a,4,5,5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a-octadecahydro-2H-cyclopenta[a]chrysen-9-yl acetate
Grundinformationen
- Standard-SMILES
CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@H]4C5=C(C(C)C)C(=O)C[C@]5(C5CN(C6(c7ncc(Cl)cn7)CC6)C(=O)O5)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C- InChIKey
NLMCYFJZRREUHX-AIHAQFFJSA-N- Summenformel
- C41H56ClN3O5
- Durchschnittliche Molmasse
- 706,4 g/mol
Namen und Bezeichner
- Bevorzugter Name
- (3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-3a-(3-(1-(5-chloropyrimidin-2-yl)cyclopropyl)-2-oxooxazolidin-5-yl)-1-isopropyl-5a,5b,8,8,11a-pentamethyl-2-oxo-3,3a,4,5,5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a-octadecahydro-2H-cyclopenta[a]chrysen-9-yl acetate
- IUPAC
- [(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-3a-[3-[1-(5-chloropyrimidin-2-yl)cyclopropyl]-2-oxo-1,3-oxazolidin-5-yl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl] acetate
Namen und Synonyme
SCHEMBL15038908NLMCYFJZRREUHX-AIHAQFFJSA-N(3aR,5aR,5bR,7aR,9S,11 aR,11bR,13aS)-3a-(3-(1-(5-chloropyrimidin-2-yl)cyclopropyl)-2-oxooxazolidin-5-yl)-1-isopropyl-5a,5b,8,8,11a-pentamethyl-2-oxo-3,3a,4,5,5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a-octadecahydro-2H-cyclopenta[a]chrysen-9-yl acetate(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-3a-(3-(1-(5-chloropyrimidin-2-yl)cyclopropyl)-2-oxooxazolidin-5-yl)-1-isopropyl-5a,5b,8,8,11a-pentamethyl-2-oxo-3,3a,4,5,5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a-octadecahydro-2H-cyclopenta[a]chrysen-9-yl acetate
Datenbank-Bezeichner
- PubChem CID
- 86690396
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 8,1
- Polarare Oberfläche (TPSA)
- 98,7 Ų
- H-Brücken-Donoren
- 0
- H-Brücken-Akzeptoren
- 7
- Frei drehbare Bindungen
- 6
- Schwere Atome
- 50
- Formalladung
- 0
- Komplexität
- 1.500
Zugehörige Reaktionen
2
Notizen zur Verbindung
Wird geladen…